It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

We got some good news from the poor old entertainment companies this earnings season. Video streaming is finally becoming a ...

NEW YORK (Reuters) -President-elect Donald Trump announced on Thursday he has selected Robert F. Kennedy Jr., an ...

I, too, am seduced by the before-and-after ads all over my Instagram feed ... There’s been talk of GLP-1 and semaglutide ...

A new spate of weight loss drugs like Ozempic and Wegovy is surging in popularity, but health experts caution they're not for ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

In a little over two decades, almost 260 million people in the United States are predicted to have overweight or obesity, ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Bhubaneswar: The Indian Army major and his betrothed, who were allegedly harassed by a group of youths and then subjected to custodial torture at Bharatpur police station on Sept 15, appeared before ...

Total Revenue: INR1,434.9 crores for Q2 FY25, up 35.3% from INR1,060.8 crores in the same period last year. Net Profit: INR676.5 crores for Q2 FY25, an increase of 83% from INR369 crores in the same ...

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.